Govind Ragupathi - Concepedia

Author

Govind Ragupathi

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

G Ragupathi, G. RAGUPATHI, G. Ragupathi, GOVIND RAGUPATHI, Govind Ragupathi, Ragupathi, Govind

100

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University University of Copenhagen Kettering University Columbia University

About

Govind Ragupathi is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	25	1.9K
2	Allergy	4	4	428
3	Natural Sciences	3	3	281
4	Engineering	2	2	91
5	Biochemistry	2	2	207

Govind Ragupathi

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes Hans H. Wandall, Ola Blixt, Mads A. Tarp, Cancer Research Sensitive Diagnostic BiomarkersImmunologyPathologyCancer BiologyTumor Biology	2010	242
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Teresa Gilewski, Sucharita Adluri, Govind Ragupathi, PubMed VaccinationMuc1 PeptideTumor ImmunologyImmunocytochemical TechniqueAllergy	2000	204
Preparation and Evaluation of Unimolecular Pentavalent and Hexavalent Antigenic Constructs Targeting Prostate and Breast Cancer: A Synthetic Route to Anticancer Vaccine Candidates Govind Ragupathi, Fusataka Koide, Philip O. Livingston, Journal of the American Chemical Society Unimolecular PentavalentImmunologyGlycobiologyPolysaccharideCarbohydrate-based Antitumor Vaccines	2006	149
Mitochondrial Ceramide-Rich Macrodomains Functionalize Bax upon Irradiation Hyunmi Lee, Jimmy A. Rotolo, Judith Mesicek, PLoS ONE	2011	148
Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer D. Chang, Haiteng Deng, Phillip Matthews, Blood	2008	142
Pilot Study of a Heptavalent Vaccine-Keyhole Limpet Hemocyanin Conjugate plus QS21 in Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Paul Sabbatini, Govind Ragupathi, Chandra Hood, Clinical Cancer Research	2007	140
Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission Brian H. Kushner, Irene Y. Cheung, Shakeel Modak, Clinical Cancer Research	2014	136
Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin Lee M. Krug, Govind Ragupathi, Chandra Hood, Clinical Cancer Research	2004	121
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer Susan F. Slovin, Govind Ragupathi, Cristina Musselli, Cancer Immunology Immunotherapy VaccinationUrologyGenitourinary CancerImmunologyTherapeutic Vaccine	2005	114
Vaccination of Small Cell Lung Cancer Patients with Polysialic Acid or<i>N</i>-Propionylated Polysialic Acid Conjugated to Keyhole Limpet Hemocyanin Lee M. Krug, Govind Ragupathi, Kenneth Ng, Clinical Cancer Research	2004	113

Page 1